Reading...
Play button
Play button
Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
17 Cards in this Set
- Front
- Back
|
Individuals treated for malaria must wait ____ years from the date treatment was finished until they are eligible to donate blood.
|
3 years
|
|
|
Individuals who were in malaria-risk areas and were required to take chemoprophylaxis because of a perceived risk of exposure must wait ____ years fro the time chemoprophylaxis was finished.
|
3 years
|
|
|
Individuals who visited malaria-risk area and remained asymptomatic, but were not required to take chemoprophylaxis because of negligible risk of exposure must wait how many months to donate blood?
|
6 months
|
|
|
True or false. Individuals who were placed on chemoprophylais initially, but did not visit the malarial-risk area require no waiting period for donating blood.
|
True
|
|
|
True or False. All Navy, Marine Corps, and MSC personnel must have a documented g6pd test result on their health record
|
True
|
|
|
Any person who is G-6-PD deficient has a risk of hemolysis associated with taking ______ for chemoprophylaxis.
|
Primaquine
|
|
|
Report suspected or confirmed malaria cases in a _____ .
|
Disease Alert Report. A malaria DAR should include the patient's itinerary during the previous 3 months and the types and duration of any chemoprophylaxis or treatment medication taken
|
|
|
What is the most important means for an individual to prevent becoming infected with malaria?
|
Personal Protective Measures
|
|
|
What are the vectors of malaria?
|
Anopheline mosquito
|
|
|
What are the chemoprophylaxis for malaria?
|
Traditionally, chloroquine and primaquine has been effective. Due to resistance to chloroquine, regimen may require the use of pyrimethamine-sulfadoxine or doxycycline.
|
|
|
Since patterns of resistance and drug requirements change frequently, Medical Department of fleet units must contact ______-
|
NAVENPVNTMEDU prior to deployment to malaria-risk areas
|
|
|
What is the Wilson-Edeson Test
|
Screening test for the presence of chloroquine in the urine. It tests for overall compliance with taking choroquine. 15% false negative rate.
|
|
|
True or false. Documented malaria, in the presence of urinary chloroquine strongly suggests a chloroquine-resistant strain.
|
True
|
|
|
The most important aspect of malaria treatment is suspecting this disease in the ________ diagnosis of the patient and beginning immediate treatment.
|
Differential
|
|
|
________ ________ malaria can progress into a rapidly fatal course.
|
Plasmodium falciparum
|
|
|
The types of parenteral antimalarial drugs used to treat severe cases of malaria are:
|
Parenteral chloroquine hydrochloride, quidine gluconate, and quinine dihydrochloride
|
|
|
True or false. Quinine-type dugs are rapidly schizonticidal and therefore rapidly reduce the level of parasitemia.
|
True
|
